VVOS financials
Vivos Therapeutics (VVOS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- VVOS revenue was $17.44M in fiscal 2025, net income -$21.23M.
VVOS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $17.44M | $10.54M | -$19.89M | -$21.23M | -2.07 |
| 2024 | $15.03M | $9.02M | -$11.17M | -$11.14M | -2.22 |
| 2023 | $13.80M | $8.27M | -$17.30M | -$13.58M | -11.14 |
| 2022 | $16.02M | $10.02M | -$25.03M | -$23.84M | -25.90 |
| 2021 | $16.89M | $12.60M | -$20.38M | -$20.29M | -0.96 |
| 2020 | $13.07M | $10.41M | -$12.04M | -$17.99M | -1.40 |